C
DXCM icon

Cerebellum’s DexCom DXCM Stock Holding History

Cerebellum’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$68K Buy
+656
New +$68.5K 0.32% 3
2019
Q2 		– Sell
-10,792
Closed -$321K – 455
2019
Q1 		$321K Buy
10,792
+2,104
+24% +$73.9K 0.28% 248
2018
Q4 		$260K Buy
8,688
+3,568
+70% +$113K 0.18% 99
2018
Q3 		$183K Sell
5,120
-2,076
-29% -$64.4K 0.29% 166
2018
Q2 		$171K Buy
+7,196
New +$153K 0.29% 232

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Cerebellum's DXCM Position: Q3 2020 in Review

Cerebellum opened a new position in DexCom (DXCM) in Q3 2020: 656 shares worth $68K. The stake represents 0.32% of the portfolio and ranks #3 among its holdings. This is a return to the name: Cerebellum previously reported a position in DXCM as recently as Q1 2019.

Cerebellum first reported a position in DXCM in Q2 2018 and has held it in 5 quarters since. The position peaked at $321K in Q1 2019. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

  • Cerebellum held 656 shares of DexCom worth $68K as of Q3 2020.
  • DexCom was a new Cerebellum position in Q3 2020.
  • DexCom made up 0.32% of Cerebellum's portfolio in Q3 2020, its #3 holding.
  • Cerebellum first reported a position in DexCom in Q2 2018 and has held it in 5 quarters since.
  • Cerebellum's DexCom position peaked at $321K in Q1 2019.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.